1m4a
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[1m4a]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1M4A OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1M4A FirstGlance]. <br> | <table><tr><td colspan='2'>[[1m4a]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1M4A OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1M4A FirstGlance]. <br> | ||
- | </td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MPE:(1H-INDOL-3-YL)-(2-MERCAPTO-ETHOXYIMINO)-ACETIC+ACID'>MPE</scene>< | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MPE:(1H-INDOL-3-YL)-(2-MERCAPTO-ETHOXYIMINO)-ACETIC+ACID'>MPE</scene></td></tr> |
- | <tr><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1m47|1m47]], [[1m48|1m48]], [[1m49|1m49]], [[1m4b|1m4b]], [[1m4c|1m4c]]</td></tr> | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1m47|1m47]], [[1m48|1m48]], [[1m49|1m49]], [[1m4b|1m4b]], [[1m4c|1m4c]]</td></tr> |
- | <tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1m4a FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1m4a OCA], [http://www.rcsb.org/pdb/explore.do?structureId=1m4a RCSB], [http://www.ebi.ac.uk/pdbsum/1m4a PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1m4a FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1m4a OCA], [http://www.rcsb.org/pdb/explore.do?structureId=1m4a RCSB], [http://www.ebi.ac.uk/pdbsum/1m4a PDBsum]</span></td></tr> |
- | <table> | + | </table> |
== Disease == | == Disease == | ||
[[http://www.uniprot.org/uniprot/IL2_HUMAN IL2_HUMAN]] Note=A chromosomal aberration involving IL2 is found in a form of T-cell acute lymphoblastic leukemia (T-ALL). Translocation t(4;16)(q26;p13) with involves TNFRSF17. | [[http://www.uniprot.org/uniprot/IL2_HUMAN IL2_HUMAN]] Note=A chromosomal aberration involving IL2 is found in a form of T-cell acute lymphoblastic leukemia (T-ALL). Translocation t(4;16)(q26;p13) with involves TNFRSF17. | ||
Line 37: | Line 37: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
- | [[Category: Arkin, M A | + | [[Category: Arkin, M A]] |
- | [[Category: Braisted, A C | + | [[Category: Braisted, A C]] |
- | [[Category: DeLano, W L | + | [[Category: DeLano, W L]] |
- | [[Category: Hyde, J | + | [[Category: Hyde, J]] |
- | [[Category: Luong, T N | + | [[Category: Luong, T N]] |
- | [[Category: McDowell, R S | + | [[Category: McDowell, R S]] |
- | [[Category: Oslob, J D | + | [[Category: Oslob, J D]] |
- | [[Category: Randal, M | + | [[Category: Randal, M]] |
- | [[Category: Raphael, D R | + | [[Category: Raphael, D R]] |
- | [[Category: Taylor, L | + | [[Category: Taylor, L]] |
- | [[Category: Wang, J | + | [[Category: Wang, J]] |
- | [[Category: Wells, J A | + | [[Category: Wells, J A]] |
[[Category: Cytokine]] | [[Category: Cytokine]] | ||
[[Category: Four-helix bundle]] | [[Category: Four-helix bundle]] | ||
[[Category: Small molecule complex]] | [[Category: Small molecule complex]] |
Revision as of 16:36, 5 January 2015
Crystal Structure of Human Interleukin-2 Y31C Covalently Modified at C31 with (1H-Indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid
|